Second window of ischemic preconditioning regulates mitochondrial permeability transition pore by enhancing Bcl-2...

Area of Science:

• Cardiovascular Science
• Mitochondrial Biology
• Cellular Physiology

Background:

• The second window of protection (SWOP) offers delayed cardioprotection after brief ischemia, but its mechanisms remain unclear.
• The mitochondrial permeability transition pore (PTP) is implicated in cell death and survival pathways.
• Investigating PTP's role in SWOP is crucial for understanding myocardial protection.

Purpose of the Study:

• To elucidate the role of the mitochondrial permeability transition pore (PTP) in the second window of protection (SWOP) against myocardial infarction.
• To determine if PTP activation state influences SWOP-mediated cytoprotective effects.

Main Methods:

• Wistar rats underwent ischemic preconditioning (IP) with brief coronary artery occlusion on day 1.
• On day 2, sustained ischemia/reperfusion was induced in IP and control rats.
• PTP activators (lonidamine, atractyloside) were administered before sustained ischemia to assess SWOP modulation.

Main Results:

• IP significantly reduced myocardial infarction area and improved cardiac function and ATP levels.
• IP led to decreased tissue water content, less mitochondrial swelling, reduced cytochrome C release, and lower apoptosis.
• PTP activators abolished SWOP's protective effects but did not affect the first window of protection.

Conclusions:

• SWOP-mediated cardioprotection is dependent on the activation state of the mitochondrial permeability transition pore (PTP).
• Upregulation of Bcl-2 expression may be involved in SWOP's protective mechanisms.
• Targeting PTP offers a potential strategy for enhancing delayed cardioprotection.